title: Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics.
abstract: Pretargeting techniques have shown promise for enhancement of the therapeutic index of radioimmunotherapy for cancer. However, methods to vary and compare antibody configurations and select optimal combinations have proved rather formidable. New options for the construction of pretargeting molecules are provided by sophisticated use of the diversity and malleability of antibody genes. Diverse arrays of single-chain antibody fragments (scFvs) can now be obtained reactive with virtually any target antigen by selection from human naive phage antibody libraries. ScFvs can also be cloned directly from hybridoma for construction of phage libraries that facilitate subsequent manipulation: e.g., affinity maturation and modification of specificity. ScFvs affinity selected from these sources to their specific antigen targets have demonstrated a wide spectrum of binding characteristics. ScFvs selected from a large human naive phage antibody library by binding Cu-1,4,8,11-tetra-azacyclotetradecane-N,N',N'',N'''-tetraacetic acid (TETA) or Y-1,4,7,10-tetra-azacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA) have shown diversity by DNA fingerprints. DNA sequence information confirmed that the anti-TETA scFv represented diverse scFv gene families. ScFvs for Y-DOTA and those for lymphoma-associated HLA DR10 (Lym-1) were selected in a similar manner from mouse antibody gene libraries derived from hybridoma. ScFv clones for each of these antigens were chosen for further study based on the results of ELISA assays involving the respective cell membrane or metal chelate antigens. A PCR primer system built to pCANTAB 5E expression vector sequence was designed to facilitate cloning of antibody heavy (V(H)) and light (V(L)) genes from selected scFvs as cassettes into diabody modules. Thus, chosen scFvs could be expressed in the same diabody format for comparative study. Selected mouse anti-DOTA scFv and Lym-1 scFv genes were linked as V(HA) anti-DOTA-link-V(LB) Lym-1; V(HB) anti-DOTA-link-V(LA) Lym-1 and ligated into the pCANTAB 5E vector. Corresponding diabodies were expressed in Escherichia coli and purified by affinity chromatography. Here we provide a perspective on the power of antibody phage libraries and the possibilities of creating simple molecular formats that can be used en route to the development of new tumor targeting and pretargeting molecules.
authors.affiliation: Department of Internal Medicine, University of California Davis Medical Center, Sacramento 95816, USA.
authors.forename: S J
authors.initials: SJ
authors.lastname: DeNardo
authors.forename: G L
authors.initials: GL
authors.lastname: DeNardo
authors.forename: D G
authors.initials: DG
authors.lastname: DeNardo
authors.forename: C Y
authors.initials: CY
authors.lastname: Xiong
authors.forename: X B
authors.initials: XB
authors.lastname: Shi
authors.forename: M D
authors.initials: MD
authors.lastname: Winthrop
authors.forename: L A
authors.initials: LA
authors.lastname: Kroger
authors.forename: P
authors.initials: P
authors.lastname: Carter
mesh_terms: D000818:Animals; D001435:Bacteriophages / Q000235:genetics*; D004797:Enzyme-Linked Immunosorbent Assay; D015723:Gene Library; D006684:HLA-DR Antigens / Q000235:genetics; D006801:Humans; D007128:Immunoglobulin Fragments / Q000235:genetics*; D051379:Mice; D008970:Molecular Weight; D009369:Neoplasms / Q000532:radiotherapy*; D016499:Radioimmunotherapy
chemical_list: D006684:HLA-DR Antigens; D007128:Immunoglobulin Fragments; C055966:immunoglobulin Fv